Enveric Biosciences, Inc.
ENVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000890821
No open-market purchases or sales by Enveric Biosciences, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $736.8K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Enveric Biosciences, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 24 | 31 | +7 |
| Shares | 2.24M | 4.78M | +2.54M (+113.5%) |
| Value | $4.64M | $4.45M | −$195.0K (−4.2%) |
New holders (9)
Institutions that held Enveric Biosciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pura Vida Investments, LLC | 742,046 | $690.0K | 0.07% |
| Ikarian Capital, LLC | 400,000 | $372.0K | 0.11% |
| Mirae Asset Global Investments Co., Ltd. | 392,920 | $365.0K | 0.00% |
| Goldman Sachs Group Inc | 58,915 | $55.0K | 0.00% |
| Group One Trading, L.P. | 52,283 | $49.0K | 0.00% |
| Boothbay Fund Management, LLC | 44,160 | $41.0K | 0.00% |
| Susquehanna International Group, LLP | 20,605 | $19.0K | 0.00% |
| Rinkey Investments | 6,500 | $5.00K | 0.00% |
| Simplex Trading, LLC | 3,158 | $2.00K | 0.00% |
Sold out (2)
Institutions that held Enveric Biosciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Squarepoint Ops LLC | 13,273 | $27.0K |
| Tower Research Capital LLC (TRC) | 3,571 | $7.00K |